QQ客服 官方微博 反馈留言

	Safety and Efficacy of Coblopasvir and Sofosbuvir in Genotype 1, 2, 3, and 6 HCV-Infected Patients with Compensated Cirrhosis or without Cirrhosis
	Jia, Jidong; Rao, Huiying; Song, Guangjun; Li, Guangming; Yang, Yongfeng; Wu, Xiaofeng; Guan, Yujuan; Mao, Qing; Jiang, Xiangjun; Wang, Changyuan
刊名	HEPATOLOGY
	2018
卷号	68
ISSN号	0270-9139
URL标识	查看原文
语种	英语
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/3538171
专题	吉林大学白求恩第一医院
推荐引用方式 GB/T 7714	Jia, Jidong,Rao, Huiying,Song, Guangjun,et al. Safety and Efficacy of Coblopasvir and Sofosbuvir in Genotype 1, 2, 3, and 6 HCV-Infected Patients with Compensated Cirrhosis or without Cirrhosis[J]. HEPATOLOGY,2018,68.
APA	Jia, Jidong.,Rao, Huiying.,Song, Guangjun.,Li, Guangming.,Yang, Yongfeng.,...&Wei, Lai.(2018).Safety and Efficacy of Coblopasvir and Sofosbuvir in Genotype 1, 2, 3, and 6 HCV-Infected Patients with Compensated Cirrhosis or without Cirrhosis.HEPATOLOGY,68.
MLA	Jia, Jidong,et al."Safety and Efficacy of Coblopasvir and Sofosbuvir in Genotype 1, 2, 3, and 6 HCV-Infected Patients with Compensated Cirrhosis or without Cirrhosis".HEPATOLOGY 68(2018).

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。